Errors in Metered Dose Inhaler Use Amongst Pediatric Asthma Patients.

"Disclosure The authors report no conflicts of interest in this work."

"MDI technique was evaluated amongst asthmatic children from a specialized respiratory clinic in Mumbai, India. This study was approved by Solutions IRB as a minimal risk study under the registration #IORG0007116 (FWA #IRB00008523). This study was conducted in accordance with the principles of the Declaration of Helsinki. A convenience sample of children within the ages of five to eighteen receiving current asthma therapy via an MDI were enrolled. Participants were required to speak, read, and understand English, provide informed consent, and comply with study demands and procedures. For patients under the age of 18, a parent or legal guardian was required to provide signed informed consent. Patients were excluded if they were undergoing long term systemic treatment for asthma including nebulizer therapy either at home, at a hospital, or a clinic or suffering from active tuberculosis, pneumonia, chronic pulmonary disease, other comorbid diseases including connective tissue disease, congestive heart failure, myocardial infarction, tumors, peripheral vascular disease, ulcer diagnosis, leukemia, dementia, liver disease, lymphoma, diabetes mellitus, hemiplegia, cerebrovascular disease, moderate or severe renal disease. No monetary compensation was provided for participation."